Trinity Biotech | TRIB - Assets


Trinity Biotech reported $103.71M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Abbott USD 86.71B 2.53B Dec/2025
Bayer EUR 104.21B 1.03B Sep/2025
Bio-Rad Laboratories USD 10.58B 880.1M Dec/2025
EDAP TMS EUR 61.46M 6.88M Sep/2025
J&J USD 199.21B 6.39B Dec/2025
Mesa Laboratories USD 434.85M 4.5M Dec/2025
OraSure Technologies USD 423.1M 21.94M Sep/2025
Plus Therapeutics USD 11.39M 1.89M Dec/2023
Roche Holding CHF 100.7B 5.94B Dec/2025
Siemens EUR 170.13B 3.93B Dec/2025
Surmodics USD 178.56M 1.15M Sep/2024
Thermo Fisher Scientific USD 110.34B 7.32B Dec/2025
Tosoh JPY 1.34T 44.3B Dec/2025
Trinity Biotech USD 103.71M 4.08M Sep/2025
Veracyte USD 1.37B 23.68M Sep/2025